AN OPEN-LABEL, MULTI-CENTER TRIAL TO ASSESS THE SAFETY OF SINGLE AND REPEAT DAXIBOTULINUMTOXINA FOR INJECTION FOR TREATMENT OF MODERATE TO SEVERE GLABELLAR LINES (SAKURA OPEN-LABEL SAFETY)
- Registry ID
- 1620303
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- REVANCE THERAPEUTICS, INC.
- Start date
- 2017-06-29
- Last update
- 2016-12-08
Conditions
Related clinical trials
- A PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE DOSE OF IPN10200 IN THE IMPROVEMENT OF MODERATE TO SEVERE GLABELLAR LINES IN ADULT PARTICIPANTS
- A DOUBLE-BLINDED RANDOMIZED CONTROLLED STUDY TO COMPARE THE EFFICACY, TIME TO ONSET, AND DURATION OF EFFECT OF BOTULINUM TYPE A TOXINS IN THE TREATMENT OF GLABELLAR FROWN LINES.
- A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, MULTI-CENTER TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF DAXIBOTULINUMTOXINA FOR INJECTION TO TREAT MODERATE TO SEVERE GLABELLAR LINES (SAKURA 2)
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, DOSE RANGING, ACTIVE AND PLACEBO CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY AND DURATION OF EFFECT OF RT002, A BOTULINUM TOXIN TYPE A FOR INJECTION, TO TREAT GLABELLAR LINES
- EVALUATION OF THE SAFETY AND EFFICACY OF TREATMENT WITH BOTOX (BOTULIUNUM TOXIN TYPE A) PURIFIED NEUROTOXIN COMPLEX FOR SUBJECTS WITH FOREHEAD AND GLABELLAR FACIAL RHYTIDES
View on source registry